News & Events

HTG Molecular Diagnostics to Present at the Cantor Fitzgerald Global Healthcare Conference

TUCSON, Ariz., Sept. 25, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents and services for molecular profiling applications, today announced its management will present a corporate overview at the Cantor Fitzgerald Global Healthcare Conference in New York City on Monday, September 25 at 9:45am Eastern Time.

full press release

Posted on:

Return To List

Page last updated December 20, 2017